Pre-order Enquiry
Request Free Sample
Global and China PD-1 and PD-L1 Antibody Market Size, Status and Forecast 2021-2027
SKU ID : QYR-19203440 | Publishing Date : 22-Sep-2021 | No. of pages : 108
Detailed TOC of Global and China PD-1 and PD-L1 Antibody Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PD-1 and PD-L1 Antibody Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PD-1 inhibitor
1.2.3 PD-L1 inhibitor
1.3 Market by Application
1.3.1 Global PD-1 and PD-L1 Antibody Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Solid Tumors
1.3.3 Blood-related Tumors
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global PD-1 and PD-L1 Antibody Market Perspective (2016-2027)
2.2 PD-1 and PD-L1 Antibody Growth Trends by Regions
2.2.1 PD-1 and PD-L1 Antibody Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 PD-1 and PD-L1 Antibody Historic Market Share by Regions (2016-2021)
2.2.3 PD-1 and PD-L1 Antibody Forecasted Market Size by Regions (2022-2027)
2.3 PD-1 and PD-L1 Antibody Industry Dynamic
2.3.1 PD-1 and PD-L1 Antibody Market Trends
2.3.2 PD-1 and PD-L1 Antibody Market Drivers
2.3.3 PD-1 and PD-L1 Antibody Market Challenges
2.3.4 PD-1 and PD-L1 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PD-1 and PD-L1 Antibody Players by Revenue
3.1.1 Global Top PD-1 and PD-L1 Antibody Players by Revenue (2016-2021)
3.1.2 Global PD-1 and PD-L1 Antibody Revenue Market Share by Players (2016-2021)
3.2 Global PD-1 and PD-L1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by PD-1 and PD-L1 Antibody Revenue
3.4 Global PD-1 and PD-L1 Antibody Market Concentration Ratio
3.4.1 Global PD-1 and PD-L1 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PD-1 and PD-L1 Antibody Revenue in 2020
3.5 PD-1 and PD-L1 Antibody Key Players Head office and Area Served
3.6 Key Players PD-1 and PD-L1 Antibody Product Solution and Service
3.7 Date of Enter into PD-1 and PD-L1 Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PD-1 and PD-L1 Antibody Breakdown Data by Type
4.1 Global PD-1 and PD-L1 Antibody Historic Market Size by Type (2016-2021)
4.2 Global PD-1 and PD-L1 Antibody Forecasted Market Size by Type (2022-2027)
5 PD-1 and PD-L1 Antibody Breakdown Data by Application
5.1 Global PD-1 and PD-L1 Antibody Historic Market Size by Application (2016-2021)
5.2 Global PD-1 and PD-L1 Antibody Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America PD-1 and PD-L1 Antibody Market Size (2016-2027)
6.2 North America PD-1 and PD-L1 Antibody Market Size by Type
6.2.1 North America PD-1 and PD-L1 Antibody Market Size by Type (2016-2021)
6.2.2 North America PD-1 and PD-L1 Antibody Market Size by Type (2022-2027)
6.2.3 North America PD-1 and PD-L1 Antibody Market Size by Type (2016-2027)
6.3 North America PD-1 and PD-L1 Antibody Market Size by Application
6.3.1 North America PD-1 and PD-L1 Antibody Market Size by Application (2016-2021)
6.3.2 North America PD-1 and PD-L1 Antibody Market Size by Application (2022-2027)
6.3.3 North America PD-1 and PD-L1 Antibody Market Size by Application (2016-2027)
6.4 North America PD-1 and PD-L1 Antibody Market Size by Country
6.4.1 North America PD-1 and PD-L1 Antibody Market Size by Country (2016-2021)
6.4.2 North America PD-1 and PD-L1 Antibody Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe PD-1 and PD-L1 Antibody Market Size (2016-2027)
7.2 Europe PD-1 and PD-L1 Antibody Market Size by Type
7.2.1 Europe PD-1 and PD-L1 Antibody Market Size by Type (2016-2021)
7.2.2 Europe PD-1 and PD-L1 Antibody Market Size by Type (2022-2027)
7.2.3 Europe PD-1 and PD-L1 Antibody Market Size by Type (2016-2027)
7.3 Europe PD-1 and PD-L1 Antibody Market Size by Application
7.3.1 Europe PD-1 and PD-L1 Antibody Market Size by Application (2016-2021)
7.3.2 Europe PD-1 and PD-L1 Antibody Market Size by Application (2022-2027)
7.3.3 Europe PD-1 and PD-L1 Antibody Market Size by Application (2016-2027)
7.4 Europe PD-1 and PD-L1 Antibody Market Size by Country
7.4.1 Europe PD-1 and PD-L1 Antibody Market Size by Country (2016-2021)
7.4.2 Europe PD-1 and PD-L1 Antibody Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific PD-1 and PD-L1 Antibody Market Size (2016-2027)
8.2 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Type
8.2.1 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Type (2016-2021)
8.2.2 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Type (2022-2027)
8.2.3 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Type (2016-2027)
8.3 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Application
8.3.1 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Application (2016-2021)
8.3.2 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Application (2022-2027)
8.3.3 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Application (2016-2027)
8.4 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Region
8.4.1 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Region (2016-2021)
8.4.2 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America PD-1 and PD-L1 Antibody Market Size (2016-2027)
9.2 Latin America PD-1 and PD-L1 Antibody Market Size by Type
9.2.1 Latin America PD-1 and PD-L1 Antibody Market Size by Type (2016-2021)
9.2.2 Latin America PD-1 and PD-L1 Antibody Market Size by Type (2022-2027)
9.2.3 Latin America PD-1 and PD-L1 Antibody Market Size by Type (2016-2027)
9.3 Latin America PD-1 and PD-L1 Antibody Market Size by Application
9.3.1 Latin America PD-1 and PD-L1 Antibody Market Size by Application (2016-2021)
9.3.2 Latin America PD-1 and PD-L1 Antibody Market Size by Application (2022-2027)
9.3.3 Latin America PD-1 and PD-L1 Antibody Market Size by Application (2016-2027)
9.4 Latin America PD-1 and PD-L1 Antibody Market Size by Country
9.4.1 Latin America PD-1 and PD-L1 Antibody Market Size by Country (2016-2021)
9.4.2 Latin America PD-1 and PD-L1 Antibody Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PD-1 and PD-L1 Antibody Market Size (2016-2027)
10.2 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Type
10.2.1 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Type (2016-2021)
10.2.2 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Type (2022-2027)
10.2.3 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Type (2016-2027)
10.3 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Application
10.3.1 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Application (2016-2021)
10.3.2 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Application (2022-2027)
10.3.3 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Application (2016-2027)
10.4 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Country
10.4.1 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Country (2016-2021)
10.4.2 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca PD-1 and PD-L1 Antibody Introduction
11.1.4 AstraZeneca Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Antibody Introduction
11.2.4 Bristol-Myers Squibb Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Details
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche PD-1 and PD-L1 Antibody Introduction
11.3.4 F. Hoffmann-La Roche Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck PD-1 and PD-L1 Antibody Introduction
11.4.4 Merck Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer PD-1 and PD-L1 Antibody Introduction
11.5.4 Pfizer Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche PD-1 and PD-L1 Antibody Introduction
11.6.4 Roche Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis PD-1 and PD-L1 Antibody Introduction
11.7.4 Novartis Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Jiangsu HengRui Medicine
11.8.1 Jiangsu HengRui Medicine Company Details
11.8.2 Jiangsu HengRui Medicine Business Overview
11.8.3 Jiangsu HengRui Medicine PD-1 and PD-L1 Antibody Introduction
11.8.4 Jiangsu HengRui Medicine Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.8.5 Jiangsu HengRui Medicine Recent Development
11.9 Innovent
11.9.1 Innovent Company Details
11.9.2 Innovent Business Overview
11.9.3 Innovent PD-1 and PD-L1 Antibody Introduction
11.9.4 Innovent Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.9.5 Innovent Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly PD-1 and PD-L1 Antibody Introduction
11.10.4 Eli Lilly Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.10.5 Eli Lilly Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Details
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline PD-1 and PD-L1 Antibody Introduction
11.11.4 GlaxoSmithKline Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.11.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global and China PD-1 and PD-L1 Antibody Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global PD-1 and PD-L1 Antibody Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PD-1 inhibitor
Table 3. Key Players of PD-L1 inhibitor
Table 4. Global PD-1 and PD-L1 Antibody Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global PD-1 and PD-L1 Antibody Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global PD-1 and PD-L1 Antibody Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global PD-1 and PD-L1 Antibody Market Share by Regions (2016-2021)
Table 8. Global PD-1 and PD-L1 Antibody Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global PD-1 and PD-L1 Antibody Market Share by Regions (2022-2027)
Table 10. PD-1 and PD-L1 Antibody Market Trends
Table 11. PD-1 and PD-L1 Antibody Market Drivers
Table 12. PD-1 and PD-L1 Antibody Market Challenges
Table 13. PD-1 and PD-L1 Antibody Market Restraints
Table 14. Global PD-1 and PD-L1 Antibody Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global PD-1 and PD-L1 Antibody Market Share by Players (2016-2021)
Table 16. Global Top PD-1 and PD-L1 Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-1 and PD-L1 Antibody as of 2020)
Table 17. Ranking of Global Top PD-1 and PD-L1 Antibody Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by PD-1 and PD-L1 Antibody Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players PD-1 and PD-L1 Antibody Product Solution and Service
Table 21. Date of Enter into PD-1 and PD-L1 Antibody Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 24. Global PD-1 and PD-L1 Antibody Revenue Market Share by Type (2016-2021)
Table 25. Global PD-1 and PD-L1 Antibody Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global PD-1 and PD-L1 Antibody Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global PD-1 and PD-L1 Antibody Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global PD-1 and PD-L1 Antibody Revenue Market Share by Application (2016-2021)
Table 29. Global PD-1 and PD-L1 Antibody Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global PD-1 and PD-L1 Antibody Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 32. North America PD-1 and PD-L1 Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America PD-1 and PD-L1 Antibody Market Size by Application (2016-2021) (US$ Million)
Table 34. North America PD-1 and PD-L1 Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America PD-1 and PD-L1 Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America PD-1 and PD-L1 Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe PD-1 and PD-L1 Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe PD-1 and PD-L1 Antibody Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe PD-1 and PD-L1 Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe PD-1 and PD-L1 Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe PD-1 and PD-L1 Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America PD-1 and PD-L1 Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America PD-1 and PD-L1 Antibody Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America PD-1 and PD-L1 Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America PD-1 and PD-L1 Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America PD-1 and PD-L1 Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 61. AstraZeneca Company Details
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca PD-1 and PD-L1 Antibody Product
Table 64. AstraZeneca Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 65. AstraZeneca Recent Development
Table 66. Bristol-Myers Squibb Company Details
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb PD-1 and PD-L1 Antibody Product
Table 69. Bristol-Myers Squibb Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 70. Bristol-Myers Squibb Recent Development
Table 71. F. Hoffmann-La Roche Company Details
Table 72. F. Hoffmann-La Roche Business Overview
Table 73. F. Hoffmann-La Roche PD-1 and PD-L1 Antibody Product
Table 74. F. Hoffmann-La Roche Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 75. F. Hoffmann-La Roche Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck PD-1 and PD-L1 Antibody Product
Table 79. Merck Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Pfizer Company Details
Table 82. Pfizer Business Overview
Table 83. Pfizer PD-1 and PD-L1 Antibody Product
Table 84. Pfizer Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 85. Pfizer Recent Development
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche PD-1 and PD-L1 Antibody Product
Table 89. Roche Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 90. Roche Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis PD-1 and PD-L1 Antibody Product
Table 94. Novartis Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 95. Novartis Recent Development
Table 96. Jiangsu HengRui Medicine Company Details
Table 97. Jiangsu HengRui Medicine Business Overview
Table 98. Jiangsu HengRui Medicine Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 99. Jiangsu HengRui Medicine Recent Development
Table 100. Innovent Company Details
Table 101. Innovent Business Overview
Table 102. Innovent PD-1 and PD-L1 Antibody Product
Table 103. Innovent Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 104. Innovent Recent Development
Table 105. Eli Lilly Company Details
Table 106. Eli Lilly Business Overview
Table 107. Eli Lilly PD-1 and PD-L1 Antibody Product
Table 108. Eli Lilly Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 109. Eli Lilly Recent Development
Table 110. GlaxoSmithKline Company Details
Table 111. GlaxoSmithKline Business Overview
Table 112. GlaxoSmithKline PD-1 and PD-L1 Antibody Product
Table 113. GlaxoSmithKline Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 114. GlaxoSmithKline Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PD-1 and PD-L1 Antibody Market Share by Type: 2020 VS 2027
Figure 2. PD-1 inhibitor Features
Figure 3. PD-L1 inhibitor Features
Figure 4. Global PD-1 and PD-L1 Antibody Market Share by Application: 2020 VS 2027
Figure 5. Solid Tumors Case Studies
Figure 6. Blood-related Tumors Case Studies
Figure 7. PD-1 and PD-L1 Antibody Report Years Considered
Figure 8. Global PD-1 and PD-L1 Antibody Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global PD-1 and PD-L1 Antibody Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global PD-1 and PD-L1 Antibody Market Share by Regions: 2020 VS 2027
Figure 11. Global PD-1 and PD-L1 Antibody Market Share by Regions (2022-2027)
Figure 12. Global PD-1 and PD-L1 Antibody Market Share by Players in 2020
Figure 13. Global Top PD-1 and PD-L1 Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-1 and PD-L1 Antibody as of 2020
Figure 14. The Top 10 and 5 Players Market Share by PD-1 and PD-L1 Antibody Revenue in 2020
Figure 15. Global PD-1 and PD-L1 Antibody Revenue Market Share by Type (2016-2021)
Figure 16. Global PD-1 and PD-L1 Antibody Revenue Market Share by Type (2022-2027)
Figure 17. North America PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America PD-1 and PD-L1 Antibody Market Share by Type (2016-2027)
Figure 19. North America PD-1 and PD-L1 Antibody Market Share by Application (2016-2027)
Figure 20. North America PD-1 and PD-L1 Antibody Market Share by Country (2016-2027)
Figure 21. United States PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe PD-1 and PD-L1 Antibody Market Share by Type (2016-2027)
Figure 25. Europe PD-1 and PD-L1 Antibody Market Share by Application (2016-2027)
Figure 26. Europe PD-1 and PD-L1 Antibody Market Share by Country (2016-2027)
Figure 27. Germany PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific PD-1 and PD-L1 Antibody Market Share by Type (2016-2027)
Figure 35. Asia-Pacific PD-1 and PD-L1 Antibody Market Share by Application (2016-2027)
Figure 36. Asia-Pacific PD-1 and PD-L1 Antibody Market Share by Region (2016-2027)
Figure 37. China PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America PD-1 and PD-L1 Antibody Market Share by Type (2016-2027)
Figure 45. Latin America PD-1 and PD-L1 Antibody Market Share by Application (2016-2027)
Figure 46. Latin America PD-1 and PD-L1 Antibody Market Share by Country (2016-2027)
Figure 47. Mexico PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa PD-1 and PD-L1 Antibody Market Share by Type (2016-2027)
Figure 51. Middle East & Africa PD-1 and PD-L1 Antibody Market Share by Application (2016-2027)
Figure 52. Middle East & Africa PD-1 and PD-L1 Antibody Market Share by Country (2016-2027)
Figure 53. Turkey PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. AstraZeneca Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 58. F. Hoffmann-La Roche Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 59. Merck Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 63. Jiangsu HengRui Medicine Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 64. Innovent Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 65. Eli Lilly Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 66. GlaxoSmithKline Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Keyplayers in Global and China PD-1 and PD-L1 Antibody Market Size, Status and Forecast 2021-2027
AstraZenecaBristol-Myers Squibb
F. Hoffmann-La Roche
Merck
Pfizer
Roche
Novartis
Jiangsu HengRui Medicine
Innovent
Eli Lilly
GlaxoSmithKline
Request Sample
Request Discount
